CoursonAJonesGMTwillaJD. Treatment of acute hepatic encephalopathy: comparing the effects of adding rifaximin to lactulose on patient outcomes. J Pharm Pract. 2016;29:212–217.
SharmaBCSharmaPLuniaMK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108:1458–1463.
4.
BassNMMullenKDSanyalA. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362:1071–1081.